CIK 0000822370
- Non-accelerated filer
- Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870419387
- Phone
- +1 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy Chairman and CEO bought 2,700 shares at an average $1.37 ($3,689)
- 4 Open-market buy Chairman and CEO bought 1,600 shares at an average $1.38 ($2,202)
- 4 Open-market buy Chairman and CEO bought 5,700 shares at an average $1.39 ($7,929)
- 4 Open-market buy Chairman and CEO bought 500 shares at $1.35 ($675)
- 4 Open-market buy Chairman and CEO bought 1,900 shares at $1.29 ($2,451)
- 4 Open-market buy Chairman and CEO bought 5,300 shares at an average $1.30 ($6,870)
- 4 Open-market buy Chairman and CEO bought 7,850 shares at an average $1.26 ($9,911)
- 4 Open-market buy Chairman and CEO bought 4,000 shares at an average $1.32 ($5,260)
- 4 Open-market buy Chairman and CEO bought 8,000 shares at an average $1.24 ($9,890)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman and CEO bought 17,300 shares at an average $1.68 ($29,021)
- 4 Open-market buy Chairman and CEO bought 9,900 shares at an average $1.29 ($12,736)
- 4 Open-market buy Chairman and CEO bought 13,000 shares at an average $1.25 ($16,235)
- 4 Open-market buy Chairman and CEO bought 30,800 shares at an average $1.26 ($38,784)
- 4 Open-market buy Chairman and CEO bought 13,200 shares at $1.21 ($15,972)
- 4 Open-market buy Vice Chairman & COO bought 4,500 shares at an average $1.26 ($5,665)
- 4 Open-market buy Chairman and CEO bought 19,200 shares at an average $1.11 ($21,364)
- 4 Open-market buy Vice Chairman & COO bought 6,800 shares at an average $1.14 ($7,770)
- 4 Open-market buy Vice Chairman & COO bought 1,500 shares at an average $1.32 ($1,980)
- 4 Open-market buy Chairman and CEO bought 4,900 shares at $1.48 ($7,252)
Page 8 of 25 · 488 filings